{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:26:30Z","timestamp":1790317590079,"version":"4.1.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.jaad.2006.02.009","type":"journal-article","created":{"date-parts":[[2006,9,29]],"date-time":"2006-09-29T09:34:08Z","timestamp":1159522448000},"page":"1048-1065","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":364,"title":["The treatment of melasma: A review of clinical trials"],"prefix":"10.1016","volume":"55","author":[{"given":"Aditya K.","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa D.","family":"Gover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyvan","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2006.02.009_bib1","series-title":"The pigmentary system physiology and pathophysiology","year":"1998"},{"key":"10.1016\/j.jaad.2006.02.009_bib2","first-page":"455","article-title":"A retrospective study on the clinical presentation and treatment outcome of melasma in a tertiary dermatological referral center in Singapore","volume":"40","author":"Goh","year":"1999","journal-title":"Singapore Med J"},{"key":"10.1016\/j.jaad.2006.02.009_bib3","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/archderm.1995.01690240119022","article-title":"Melasma: etiologic and therapeutic considerations","volume":"131","author":"Grimes","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib4","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0190-9622(81)70071-9","article-title":"Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study","volume":"4","author":"Sanchez","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib5","first-page":"271","article-title":"Epidemiology of skin diseases in people of color","volume":"71","author":"Taylor","year":"2003","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.02.009_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0733-8635(05)70150-9","article-title":"Disorders of hyperpigmentation","volume":"18","author":"Pandya","year":"2000","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2006.02.009_bib7","series-title":"The pigmentary system physiology and pathology","first-page":"909","article-title":"Mixed epidermal and dermal hypermelanoses","author":"Urabe","year":"1998"},{"key":"10.1016\/j.jaad.2006.02.009_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-4362.1988.tb02329.x","article-title":"Melasma in men: a clinical and histologic study","volume":"27","author":"Vazquez","year":"1988","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib9","first-page":"131","article-title":"Dermatoses of pregnancy","volume":"37","author":"Sodhi","year":"1988","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jaad.2006.02.009_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/jama.1967.03120090043007","article-title":"Melasma induced by oral contraceptive drugs","volume":"199","author":"Resnik","year":"1967","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2006.02.009_bib11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1210\/jcem-61-1-28","article-title":"Association of melasma with thyroid autoimmunity and other thyroidal abnormalities and their relationship to the origin of the melasma","volume":"61","author":"Lutfi","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2006.02.009_bib12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/1523-1747.ep12522896","article-title":"Endocrinologic profile of patients with idiopathic melasma","volume":"81","author":"Perez","year":"1983","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.0007-0963.2001.04556.x","article-title":"Melasma: histopathological characteristics in 56 Korean patients","volume":"146","author":"Kang","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib14","first-page":"192","article-title":"Melasma: a mask of stress","volume":"125","author":"Wolf","year":"1991","journal-title":"Br\u00a0J\u00a0Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib15","first-page":"239","article-title":"Topical tretinoin, hydroquinone, and betamethasone valerate in the therapy of melasma","volume":"23","author":"Gano","year":"1979","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.02.009_bib16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1600-0749.1996.tb00110.x","article-title":"Effect of pituitary and ovarian hormones on human melanocytes in vitro","volume":"9","author":"Maeda","year":"1996","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.jaad.2006.02.009_bib17","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00042728-200302000-00022","article-title":"Melasma in Indian males","volume":"29","author":"Sarkar","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2006.02.009_bib18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2133.1977.tb06132.x","article-title":"Localization of malanin pigmentation in the skin with Wood's lamp","volume":"96","author":"Gilchrest","year":"1977","journal-title":"Br\u00a0J Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib19","series-title":"Evidence-based dermatology","first-page":"553","article-title":"Melasma","author":"Salim","year":"2003"},{"key":"10.1016\/j.jaad.2006.02.009_bib20","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1046\/j.1365-4362.1998.00585.x","article-title":"Treatment of melasma: a review with personal experience","volume":"37","author":"Piamphongsant","year":"1998","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib21","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0190-9622(86)70247-8","article-title":"Usefulness of retinoic acid\u00a0in the treatment of melasma","volume":"15","author":"Pathak","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib22","article-title":"The efficacy of a broad-spectrum sunscreen in the treatment of melasma","volume":"32","author":"Vazquez","year":"1983","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.02.009_bib23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0304-4165(91)90186-K","article-title":"Mechanism of inhibition of melanogenesis by hydroquinone","volume":"1073","author":"Palumbo","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jaad.2006.02.009_bib24","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-4362.1998.00499.x","article-title":"Topical hydroquinone in the treatment of\u00a0some hyperpigmentary disorders","volume":"37","author":"Amer","year":"1998","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1365-4362.2003.01621.x","article-title":"A clinical, prospective, randomized, double-blind trial comparing skin whitening complex with hydroquinone vs placebo in the treatment of melasma","volume":"42","author":"Haddad","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib26","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1001\/archderm.138.12.1578","article-title":"Efficacy of\u00a0glycolic acid peels in the treatment of melasma","volume":"138","author":"Hurley","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib27","series-title":"AHFS drug information","year":"2004"},{"key":"10.1016\/j.jaad.2006.02.009_bib28","first-page":"1391","article-title":"Cutaneous reactions to topical application of hydroquinone: results of a 6-year investigation","volume":"49","author":"Bentley-Phillips","year":"1975","journal-title":"S Afr Med J"},{"key":"10.1016\/j.jaad.2006.02.009_bib29","first-page":"58","article-title":"Double-blind comparison of azelaic acid and\u00a0hydroquinone in the treatment of melasma","volume":"143","author":"Verallo-Rowell","year":"1989","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"10.1016\/j.jaad.2006.02.009_bib30","series-title":"The pigmentary system physiology and pathology","first-page":"969","article-title":"Topical treatment of pigmentary disorders","author":"Halder","year":"1998"},{"key":"10.1016\/j.jaad.2006.02.009_bib31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/archderm.1975.01630130042004","article-title":"A new formula for depigmenting human skin","volume":"111","author":"Kligman","year":"1975","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib32","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2133.1993.tb03169.x","article-title":"Topical tretinoin (retinoic acid) improves melasma: a vehicle-controlled, clinical trial","volume":"129","author":"Griffiths","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib33","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/archderm.1994.01690060057005","article-title":"Topical retinoic acid (tretinoin) for melasma in black patients: a vehicle-controlled clinical trial","volume":"130","author":"Kimbrough-Green","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib34","series-title":"Physicians' desk reference","year":"2003"},{"key":"10.1016\/j.jaad.2006.02.009_bib35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0190-9622(81)70049-5","article-title":"The therapeutic uses of topical vitamin A acid","volume":"4","author":"Thomas","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib36","series-title":"USP DI: drug information for the health care professional","year":"2004"},{"key":"10.1016\/j.jaad.2006.02.009_bib37","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000247129","article-title":"Treatment of melasma with potent topical corticosteroids","volume":"188","author":"Kanwar","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2006.02.009_bib38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000251359","article-title":"Treatment of melasma (chloasma) by local application of a steroid cream","volume":"151","author":"Neering","year":"1975","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2006.02.009_bib39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-4362.1982.tb00498.x","article-title":"Topical corticosteroids","volume":"21","author":"Robertson","year":"1982","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib40","first-page":"67","article-title":"Efficacy and safety of a new triple-combination agent for the treatment of facial melasma","volume":"72","author":"Taylor","year":"2003","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.02.009_bib41","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0190-9622(89)70159-6","article-title":"Topical all-trans-retinoic acid prevents corticosteroid-induced skin atrophy without abrogating the anti-inflammatory effect","volume":"21","author":"Lesnik","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib42","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1046\/j.1365-2133.1996.d01-933.x","article-title":"Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy","volume":"135","author":"McMichael","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib43","first-page":"57","article-title":"Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma","volume":"75","author":"Torok","year":"2005","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2006.02.009_bib44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/1523-1747.ep12547184","article-title":"Identification of tyrosinase inhibitors\u00a0in cultures of Pityrosporum","volume":"71","author":"Nazzaro-Porro","year":"1978","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib45","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/BF00372056","article-title":"Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases","volume":"283","author":"Akamatsu","year":"1991","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2006.02.009_bib46","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0149-2918(98)80076-3","article-title":"Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients","volume":"20","author":"Lowe","year":"1998","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaad.2006.02.009_bib47","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1365-4362.1991.tb04362.x","article-title":"The treatment of melasmaz: 20% azelaic acid\u00a0versus 4% hydroquinone cream","volume":"30","author":"Balina","year":"1991","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib48","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0149-2918(98)80077-5","article-title":"Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone","volume":"20","author":"Kakita","year":"1998","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaad.2006.02.009_bib49","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1524-4725.1999.08236.x","article-title":"Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid","volume":"25","author":"Lim","year":"1999","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2006.02.009_bib50","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1524-4725.1996.tb00345.x","article-title":"The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions","volume":"22","author":"Garcia","year":"1996","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2006.02.009_bib51","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2133.1976.tb05169.x","article-title":"The treatment of hypermelanosis with 4-isopropylcatechol","volume":"94","author":"Bleehen","year":"1976","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib52","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/archderm.1991.01680090092011","article-title":"N-acetyl-4-S-cysteaminylphenol as a new type of depigmenting agent for the melanoderma of patients with melasma","volume":"127","author":"Jimbow","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib53","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2133.1991.tb03282.x","article-title":"Selective cytotoxicity of N-acetyl-4-S-cysteaminylphenol on follicular melanocytes of black mice","volume":"124","author":"Wong","year":"1991","journal-title":"Br\u00a0J Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib54","first-page":"868","article-title":"Topical isotretinoin for melasma in Thai patients: a vehicle-controlled clinical trial","volume":"82","author":"Leenutaphong","year":"1999","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.jaad.2006.02.009_bib55","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1346-8138.2002.tb00324.x","article-title":"Adapalene in the treatment of melasma: a preliminary report","volume":"29","author":"Dogra","year":"2002","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib56","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1021\/jf020935u","article-title":"Glabrene and isoliquiritigenin as tyrosinase inhibitors from licorice roots","volume":"51","author":"Nerya","year":"2003","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.jaad.2006.02.009_bib57","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-4362.2000.00943.x","article-title":"Topical liquiritin improves melasma","volume":"39","author":"Amer","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib58","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0190-9622(96)90830-0","article-title":"Inhibitory effect of magnesium L-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo","volume":"34","author":"Kameyama","year":"1996","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib59","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ptr.1085","article-title":"Treatment of melasma with Pycnogenol","volume":"16","author":"Ni","year":"2002","journal-title":"Phytother Res"},{"key":"10.1016\/j.jaad.2006.02.009_bib60","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ptr.1537","article-title":"Oral intake of proanthocyanidin-rich extract from grape seeds improves chloasma","volume":"18","author":"Yamakoshi","year":"2004","journal-title":"Phytother Res"},{"key":"10.1016\/j.jaad.2006.02.009_bib61","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1524-4725.1999.08145.x","article-title":"The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups","volume":"25","author":"Grimes","year":"1999","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2006.02.009_bib62","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0733-8635(18)30441-8","article-title":"Chemical face peels","volume":"9","author":"Matarasso","year":"1991","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2006.02.009_bib63","first-page":"512","article-title":"Focal trichloroacetic acid peel method for benign pigmented lesions in dark-skinned patients","volume":"30","author":"Chun","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2006.02.009_bib64","first-page":"12","article-title":"Tretinoin peeling","volume":"27","author":"Cuce","year":"2001","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2006.02.009_bib65","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-4362.1993.tb05024.x","article-title":"50% Resorcinol peel","volume":"32","author":"Karam","year":"1993","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib66","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1046\/j.1365-4362.2001.01149.x","article-title":"Safety and efficacy of\u00a0glycolic acid facial peel in Indian women with melasma","volume":"40","author":"Javaheri","year":"2001","journal-title":"Int\u00a0J Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib67","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1524-4725.1997.tb00016.x","article-title":"Glycolic acid peels in the treatment of melasma among Asian women","volume":"23","author":"Lim","year":"1997","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2006.02.009_bib68","first-page":"828","article-title":"The combination of\u00a0glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: a comparative study","volume":"28","author":"Sarkar","year":"2002","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2006.02.009_bib69","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s002660010107","article-title":"Dermabrasion: a curative treatment for melasma","volume":"25","author":"Kunachak","year":"2001","journal-title":"Aesthetic Plast Surg"},{"key":"10.1016\/j.jaad.2006.02.009_bib70","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00042728-200104000-00016","article-title":"Intense pulsed light for melanocytic lesions","volume":"27","author":"Moreno Arias","year":"2001","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2006.02.009_bib71","first-page":"1196","article-title":"Intense pulsed light for the treatment of refractory melasma in Asian persons","volume":"30","author":"Wang","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2006.02.009_bib72","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0733-8635(05)70449-6","article-title":"Laser treatment of pigmented lesions","volume":"15","author":"Goldberg","year":"1997","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2006.02.009_bib73","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/1523-1747.ep12277339","article-title":"Selective photothermolysis of cutaneous pigmentation by Q-switched Nd:YAG laser pulses at 1064,\u00a0532, and 355\u00a0nm","volume":"93","author":"Anderson","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2006.02.009_bib74","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00000637-199209000-00007","article-title":"Treatment of superficial cutaneous pigmented lesions by melanin-specific selective photothermolysis using the Q-switched ruby laser","volume":"29","author":"Nelson","year":"1992","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.jaad.2006.02.009_bib75","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1524-4725.2000.00039.x","article-title":"An in vivo trial comparing the use of different types of 532 nm Nd:YAG lasers in the treatment of facial lentigines in Oriental patients","volume":"26","author":"Chan","year":"2000","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2006.02.009_bib76","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1524-4725.1994.tb03707.x","article-title":"The removal of cutaneous pigmented lesions with the Q-switched ruby laser and the Q-switched neodymium: yttrium-aluminum-garnet laser: a comparative study","volume":"20","author":"Tse","year":"1994","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1016\/j.jaad.2006.02.009_bib77","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1524-4725.1993.tb00360.x","article-title":"Benign pigmented lesions of the skin: treatment with the Q-switched ruby laser","volume":"19","author":"Goldberg","year":"1993","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1016\/j.jaad.2006.02.009_bib78","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1524-4725.1994.tb00152.x","article-title":"Ineffective treatment of refractory melasma and postinflammatory hyperpigmentation by Q-switched ruby laser","volume":"20","author":"Taylor","year":"1994","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1016\/j.jaad.2006.02.009_bib79","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1524-4725.1999.08248.x","article-title":"Combination treatment of melasma with pulsed CO2 laser followed by Q-switched alexandrite laser: a pilot study","volume":"25","author":"Nouri","year":"1999","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2006.02.009_bib80","first-page":"59","article-title":"Combined ultrapulse CO2 laser and Q-switched alexandrite laser compared with Q-switched alexandrite laser alone for refractory melasma: split-face design","volume":"29","author":"Angsuwarangsee","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2006.02.009_bib81","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1524-4725.1999.08103.x","article-title":"Erbium:YAG laser resurfacing for refractory melasma","volume":"25","author":"Manaloto","year":"1999","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2006.02.009_bib82","series-title":"The pigmentary system physiology and pathphysiology","first-page":"995","article-title":"Laser treatment of pigmentary disorders","author":"Halder","year":"1998"},{"key":"10.1016\/j.jaad.2006.02.009_bib83","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1524-4725.1993.tb00361.x","article-title":"510-nm Pigmented lesion dye laser: its characteristics and clinical uses","volume":"19","author":"Grekin","year":"1993","journal-title":"J\u00a0Dermatol Surg Oncol"},{"key":"10.1016\/j.jaad.2006.02.009_bib84","unstructured":"Health Canada. Drug product database. Available from: URL: http:\/\/www.hc-sc.gc.ca\/hpb\/drugs-dpd. Accessed April 9, 2005."}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962206005238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962206005238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:05:00Z","timestamp":1759269900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962206005238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":84,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0190962206005238"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2006.02.009","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The treatment of melasma: A review of clinical trials","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2006.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}